肺癌沙丘症临床试验终点:德尔菲研究
Robert P Baughman1, Jan C Grutters2,3, Elyse E Lower1
1University of Cincinnati Department of Medicine, Cincinnati, OH, USA.
在肺性沙科毒症的38项临床试验终点上达成共识,有助于开发新的皮质类固醇节约治疗方法. 这些终点侧重于减少类固醇使用,改善肺功能和整体健康.
科学领域:
- 肺部医学 肺部医学
- 临床试验设计 临床试验设计
- 类风湿病学 类风湿病学
背景情况:
- 皮质类固醇是对类固醇的首要治疗方法,但会导致显著的长期毒性.
- 开发新疗法以减少或消除皮质类固醇使用需要精确的临床试验终点.
- 目前缺乏关于肺性沙尔科毒症试验终点的共识.
研究的目的:
- 建立关于肺癌沙尔科毒症临床试验终点的共识.
- 确定评估新型类固醇节约疗法的试验的具体终点.
主要方法:
- 一个德尔菲调查与30名 Sarcoidosis 调查人员的专家小组进行了调查.
- 最初97个关于潜在终点的陈述在第二轮匿名投票中得到了改进.
- 利益相关者,包括70名额外的个人,审查和投票对精细的陈述.
主要成果:
- 在六个领域的组合终点和38个具体陈述上达成共识.
- 关键的终点包括50%的普得尼松减少或停止治疗.
- 此外,FVC%,FEV1%,DLCO%的改善,以及国王肉病问卷 (KSQ) 也得到了同意.
结论:
- 德尔菲技术促进了国际专家在38个临床试验终点上达成共识 肺癌沙丘病.
- 这些终点对于开发可减少或消除皮质类固醇依赖的创新疗法至关重要.
- 达成的共识为未来临床试验的基础,用于肺性沙丘病管理.
更多相关视频
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Clinical Trials: Overview
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
